Uvadex

Uvadex (Methoxsalen) is a psoralen compound used in extracorporeal photopheresis therapy for skin conditions. This treatment combines medication with light exposure to support immune modulation. Ideal for patients seeking adjunctive care under medical supervision. Short-term use only.

Methoxsalen is primarily used in extracorporeal photopheresis, a procedure where the drug is activated by UVA light outside the body to help regulate immune responses. It is indicated as an adjunctive treatment for severe skin conditions like cutaneous T-cell lymphoma. Patients often ask, 'what is Methoxsalen used for' in the context of light-activated therapy. This method supports the body’s natural processes under controlled clinical settings.

Methoxsalen works by making skin cells more sensitive to UVA light during treatment. When exposed to light, it helps modulate immune activity without causing widespread systemic effects. Users may notice temporary skin sensitivity following sessions. The body’s response varies based on individual health and treatment protocols.

Methoxsalen should only be handled and administered by healthcare professionals in a clinical environment. Patients must avoid direct sunlight and UV exposure for at least 24 hours after treatment to prevent excessive skin reactions. Protective eyewear is typically required during and after sessions. Always follow medical guidance for safe use.

Methoxsalen can interact with other drugs that increase skin sensitivity to light, such as certain antibiotics or diuretics. Combining it with herbal supplements like St. John’s Wort may heighten this effect. Alcohol and tobacco use may also influence treatment outcomes. Discuss all medications with your healthcare provider before starting therapy.